ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.
Also called NCT02301819
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 122 participants
- Registry
-
NCT02301819
-
- Main results
- Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial
- Other papers using this trial's data
- Cardiac index, SvO2 or pCO2 gap may determine benefit from ECMO in cardiogenic shock: post-hoc analysis of the multicenter, randomized ECMO-CS trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia
- Registry status
- Completed
Technical summary
Registry record NCT02301819. Randomized; single masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2022-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock
- Acronym
- ECMO-CS
- Condition
- Cardiogenic Shock
- Intervention (Device)
- Veno-arterial extracorporeal membrane oxygenation (ECMO)
- Intervention (Other)
- Early conservative therapy according to standard practice
- Lead sponsor
- Na Homolce Hospital
- Collaborator
- General University Hospital, Prague
- Collaborator
- University Hospital Pilsen
Record details
- Record id
cardio:ct-nct02301819- Content hash
350d9dc980fd665f2e0876bc34f96f564e6c09ae48cdd574bb2c840e2c602bce